Shanghai InnoStar Bio-tech Co. Ltd.SSE: 688710

Announcement on Convening the Q3 2025 Performance Briefing

Nov 14, 2025 · Issued by Shanghai InnoStar Bio-tech Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Nov 14, 2025

On 6ix: 6ix.com/news/announcement-on-convening-the-q3-2025-performance-briefing-1069

Announcement on Convening the Q3 2025 Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Shanghai InnoStar Bio-tech Co. Ltd. on 6ix

Earlier from Shanghai InnoStar Bio-tech

Indicative Announcement on Report on Results of Shareholders' Inquiry Transfer and Equity Change of Shareholders with Over 5% Shares Reaching 5% Integer MultipleNov 11, 2025
Report for Q3 2025Oct 31, 2025
Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025Sep 24, 2025
Announcement on Change of Company Website and Investor AddressSep 13, 2025
Announcement on Purchasing Liability Insurance for Directors, Supervisors, and Senior Management MembersAug 29, 2025

Later from Shanghai InnoStar Bio-tech

Announcement on Resolutions of the 4th Extraordinary General Meeting in 2025Nov 29, 2025
Announcement on Shareholding Reduction Plan for ShareholdersDec 20, 2025
Announcement on Progress in Business Adjustment of Holding SubsidiaryDec 31, 2025
Announcement on Equity Change of Shareholders Reaching 1% Scale and Results of Shareholding ReductionJan 9
Announcement on Abnormal Fluctuations in Stock TradingJan 10

All Shanghai InnoStar Bio-tech news releases

Follow Shanghai InnoStar Bio-tech into a list and get an email when it puts out news.

Follow Shanghai InnoStar Bio-tech